✦ LIBER ✦

2-12-04 Alzheimer disease and tacrine

✍ Scribed by F. Herrero

Book ID: 119469306
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 176 KB
Volume: 150
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(97)85252-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2-12-15 Tacrine and extrapyramidal signs

2-12-15 Tacrine and extrapyramidal signs in Alzheimer's disease

✍ J. Kulisevsky; A. Ávila; A. Gironell; M. Berthier; A. Escartin; G. Hernández 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 165 KB

The effect of tacrine and lecithin in Al

The effect of tacrine and lecithin in Alzheimer's disease

✍ K. Peace; N. H. G. Holford 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 602 KB

Tacrine, a cholinesterase inhibitor, has beneficial effects on cognition and global status in patients with Alzheimer's disease. These effects have been demonstrated in clinical trials by double-blind comparisons with placebo. Tacrine dosages have been studied in 5 protocols that used either enrichm

Lewy bodies and response to tacrine in A

Lewy bodies and response to tacrine in Alzheimer's disease

✍ Raymond Levy; Sarah Eagger; Martin Griffiths; Elaine Perry; Mrinalini Honavar; A 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 151 KB

Combined Tacrine and Estrogen Replacemen

Combined Tacrine and Estrogen Replacement Therapy in Patients with Alzheimer's Disease

✍ LON S. SCHNEIDER; MARTIN FARLOW 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB

O2-04-04 Relations between cerebral amyl

O2-04-04 Relations between cerebral amyloid angiopathy and Alzheimer's disease pathology

✍ Johannes Attems; Felix Lintner; Kurt A. Jellinger 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

1-12-09 P 300 and Alzheimer disease

✍ M.F. Casanova; J.A. Cabrera; R. Fernández; E. Santana 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 172 KB